Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.

Insurance & Coverage — 2026 Verified Guide

GLP-1 Providers That Accept Centene (2026 Coverage Map for Ambetter, Wellcare & Medicaid)

By The RX Index Editorial Team

Published: May 2, 2026 · Last updated: May 3, 2026 · Last reviewed: May 3, 2026

Last verified: May 2, 2026 against Centene clinical policies CP.PMN.295 and CP.PMN.298, the CMS Medicare GLP-1 Bridge page, Wellcare's Medicare resource page, KFF's January 2026 Medicaid GLP-1 tracker, and each provider's public pricing.

The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. Some links on this page are affiliate links — if you start care through them, we may earn a commission at no extra cost to you. It does not change which providers we recommend. See our editorial standards and methodology.

Here's the short version on GLP-1 providers that accept Centene. Almost no big telehealth GLP-1 platform is actually “in-network” with Centene the way an in-person specialist is. The real question — the one that decides whether your medication gets paid for — is which platform will run a prior authorization (PA) through your Centene pharmacy benefit. And the answer depends on which Centene plan you have.

If your card says Ambetter (Centene's ACA Marketplace brand), Ro is the strongest first move because it offers a free GLP-1 Insurance Coverage Checker and an insurance concierge that handles PA paperwork. Sesame Care is a solid second option if you want to pick your own provider or try branded self-pay pricing.

If your card says Wellcare (Centene's Medicare brand), the picture changes on July 1, 2026. That's when the federal Medicare GLP-1 Bridge opens nationwide to eligible Part D and MA-PD members — Wellcare included. Part D plans don't have to opt in. Eligible members may be able to access Wegovy®, the Zepbound® KwikPen, or Foundayo™ for a flat $50 copay through CMS's central processor.

If you have Centene Medicaid (Sunshine Health, Peach State, Superior, Sunflower, Meridian, Health Net Medi-Cal, and others), the answer is mostly state-by-state. Centene's own clinical policy CP.PMN.295 calls weight-management Wegovy a “benefit exclusion.” But there are real comorbidity pathways most readers don't know exist — and we'll show you which ones.

Below is the exact map for every Centene plan type, what your medication will actually cost, the prior authorization documents you'll need, and what to do if Centene denies you.

Pick Your Path (Above-the-Fold Decision Table)

Why “GLP-1 Providers That Accept Centene” Is the Wrong Question (And the Right One)

That distinction is everything. When you ask “does Ro accept Centene?” you might be asking three different things:

1. “Will Ro bill my Centene plan for the doctor visit?” Almost always no. Telehealth memberships are cash-pay.
2. “Will the GLP-1 medication Ro prescribes get covered by Centene?” Maybe — depends on your plan, your diagnosis, and prior authorization.
3. “Will Ro help me fight for that medication coverage?” For commercial Ambetter members, yes. For Wellcare Medicare and Centene Medicaid, no — Ro publicly states it doesn't coordinate GLP-1 coverage for government-funded plans.

Once you separate those three things, the whole picture gets simpler. The membership cost is what you pay for the doctor and the support. The medication cost is a separate line. And whether Centene picks up the medication tab depends on rules Centene already wrote down — which we'll get to in a minute.

This is also why a Medicaid member should almost never start with a paid telehealth subscription. You'll pay for a service that can't move the needle on Medicaid pharmacy coverage. Use your plan's in-network provider directory instead. We'll show you when to break that rule and when not to.

Step One: Identify Your Actual Centene Plan

Plan Decoder Table

Where to Find the Plan Name

On the front of your insurance card. In your member portal under “plan details.” On any letter Centene has ever sent you — denial letters always print the plan brand at the top. On your prescription benefit card if it's separate from your medical card.

If you can't find it, call the member services number on the back of your card and ask: “What's the exact plan name and product type — Marketplace, Medicare, or Medicaid?” That answer changes every other step on this page.

What Centene's Own Clinical Policy Actually Says About GLP-1s for Weight Loss

This is the part competing pages don't show you. Centene wrote the rules down — you can read them yourself. The Wegovy® policy CP.PMN.295 (last reviewed February 2026) explicitly calls weight management a “benefit exclusion.” The same exclusion language appears in CP.PMN.298 for Zepbound®.

Translation in plain English: If your prescription says “for weight loss,” it gets denied. If your prescription documents a different FDA-approved reason and you meet the criteria, it can get covered.

That's not a loophole. It's how the policy is written. And it changes the entire conversation about which provider to use.

The Coverage Pathways That Actually Work for Centene

For Wegovy® cardiovascular pathway requests where the member also has type 2 diabetes, Centene's policy generally requires step therapy through Ozempic®/Rybelsus® → Trulicity® → Victoza® first, unless those medications were intolerable or contraindicated. (Illinois HIM members got an exception starting January 1, 2026 under state law HB 5395.)

This is also where the timing of your medical history starts to matter. If you've ever had a sleep study, a cardiac event, peripheral artery disease, a fatty liver diagnosis, or a stroke, ask your prescriber whether one of these pathways applies to you. A lot of denials happen because nobody bothered to look.

Note: Wellcare Medicare follows Medicare Part D rules and CMS guidance — not the same Ambetter/Medicaid clinical policy framework — so the exact criteria can differ from CP.PMN.295/.298.

The Best Telehealth Providers for Centene Members (Ranked by Plan Type)

Provider Comparison: Who Will Actually Help With Centene Coverage

Now let's get into who actually fits your situation.

Ro: The Best Fit for Ambetter Members Who Want FDA-Approved Brand-Name Medication

Why Ro is our top pick for Ambetter members: Ro publicly carries the major FDA-approved brand-name GLP-1s (Wegovy® pen, Wegovy® pill, Zepbound® KwikPen) and runs a free GLP-1 Insurance Coverage Checker that tells you whether your Ambetter plan will cover Ozempic®, Wegovy®, or Zepbound® before you sign up for anything. If your insurance requires prior authorization, Ro's insurance concierge submits the paperwork on your behalf.

Pricing: Get started for $39, then as low as $74/month with annual plan paid upfront. Standard ongoing pricing is $149/month if you don't prepay annually. Medication cost is separate.

Who Ro is best for:

• You have Ambetter (or another commercial/Marketplace plan) and want help fighting for coverage
• You want an FDA-approved brand-name medication, not a compounded alternative
• You qualify for one of Centene's coverable indications (CV event prevention, OSA, MASH) and need someone to handle the PA paperwork
• You'd rather have a dedicated insurance concierge than ask your PCP to figure out Centene's clinical criteria

The honest limitation — and why it actually makes the recommendation cleaner: Ro doesn't coordinate GLP-1 coverage for government insurance plans. If you have Wellcare Medicare or Centene Medicaid, Ro will tell you upfront they can't help on the insurance side. Medicaid members specifically cannot enroll in Ro Body. If that's you, scroll down to the Wellcare or Medicaid section — we have a different play for you.

But for Ambetter Marketplace members? That same limitation is the reason Ro's commercial PA process is sharp. They're not trying to be everything for everyone. They focus on the lane where their insurance concierge actually has leverage. The free Coverage Checker means you can find out exactly where your plan stands on Wegovy® or Zepbound® without paying a dollar of membership.

Sesame Care (Success by Sesame): Best for Provider Choice and Branded Self-Pay Backup

Why Sesame is our strong second pick: Sesame Care runs a marketplace model where you pick your own provider based on reviews, experience, and credentials — instead of being assigned a random clinician. Their Success by Sesame program shows a broad medication menu including Wegovy® pill, Wegovy® pen, Zepbound® KwikPen, Foundayo™, Ozempic®, and other options. Sesame providers can help with prior authorization paperwork, and the platform offers branded cash-pay options including a Costco partnership pathway for Wegovy® and Ozempic®.

Pricing: Success by Sesame starts at $59/month on annual plan ($99/month month-to-month). Medication cost is separate.

Who Sesame is best for:

• You want to pick your own provider rather than be assigned one
• You're not sure yet whether you want Wegovy®, Zepbound®, Foundayo™, or something else and you want options
• Your Ambetter PA was denied and you want a branded self-pay backup
• You're a Costco member and want to use the Sesame–Costco pathway

The honest limitation: Sesame doesn't bill insurance for the consult. The $59–$99/month subscription is cash-pay regardless of your Centene plan. The medication may still get covered if PA goes through, but you won't see a $25 specialist copay for the doctor visit show up on your insurance.

WeightWatchers Clinic (Med+): Behavior Change + Insurance Coordination

WeightWatchers Clinic is worth a quick mention because their Med+ program includes an insurance coordinator who handles prior authorization and refills. Pricing starts at $25 the first month, then about $74/month on the annual plan. The platform now prescribes FDA-approved Wegovy® (pill access through Med+) following its Novo Nordisk partnership.

Best fit: You want behavior-change coaching alongside medication, you trust the WW brand, and your Ambetter or commercial plan can be billed for the medication.

Skip if: You have Wellcare Medicare or Centene Medicaid — same government-plan limitation as Ro and Sesame.

Hims and Hers: Cash-Pay FDA-Approved Brand Names

Following the March 2026 Novo Nordisk partnership, Hims and Hers now offer access to FDA-approved Wegovy® pill, Wegovy® pen, and Ozempic®. Neither platform actively coordinates Centene insurance coverage — they're primarily cash-pay subscription models. Use them only if you've already decided to go cash-pay or your Centene PA was denied and you want a familiar mainstream telehealth brand for the medication.

In-Network Centene Clinician: The Right First Move for Wellcare and Medicaid

For Wellcare Medicare and Centene Medicaid members, an in-network plan provider is almost always the better starting point than any paid telehealth subscription. Why? Because your visit gets billed to the plan, the prescriber knows your plan's formulary and PA criteria firsthand, and there's no membership fee on top.

Find one through your plan's “Find a Provider” directory. Search for “obesity medicine,” “endocrinology,” or “internal medicine — weight management.” Many primary care providers also handle GLP-1 prescriptions and PA submissions in-house.

Does Wellcare Cover GLP-1s for Weight Loss? The Big Change Coming July 1, 2026

This is the biggest GLP-1 access change in 20+ years for Medicare beneficiaries. Federal law has prohibited Medicare from covering medications prescribed solely for weight loss since 2003. The Bridge is a CMS demonstration program that operates outside normal Part D rules to provide a temporary path.

What Wellcare Currently Covers (Today, Before the Bridge)

Wellcare's published guidance is clear: weight-loss-only GLP-1 use is excluded under Medicare Part D. But these GLP-1s are coverable for non-weight-loss FDA-approved uses:

• Ozempic®, Rybelsus®, Trulicity®, Victoza®, Mounjaro® — covered for type 2 diabetes when on plan formulary
• Wegovy® — covered to reduce risk of cardiovascular death, heart attack, or stroke in adults with established cardiovascular disease who are overweight or obese
• Zepbound® — covered for moderate-to-severe obstructive sleep apnea in adults with obesity

If you have Wellcare and one of those non-weight-loss indications, the Bridge is not the route. The request goes through your Part D plan's normal formulary, prior authorization, and exception process.

What the Medicare GLP-1 Bridge Covers Starting July 1, 2026

Three drugs only:

• Wegovy® (all formulations — injection and tablets)
• Zepbound® KwikPen only (single-dose vials and single-dose pens are NOT included)
• Foundayo™ (orforglipron, the new oral GLP-1 approved by the FDA on April 1, 2026 for chronic weight management)

Who Qualifies for the Bridge

You only need to meet one of these BMI tiers, plus baseline requirements:

• Tier 1: BMI ≥ 35 (no other condition needed)
• Tier 2: BMI ≥ 30 + heart failure with preserved ejection fraction, uncontrolled hypertension on 2+ medications, or chronic kidney disease stage 3a or higher
• Tier 3: BMI ≥ 27 + prediabetes, prior heart attack, prior stroke, or peripheral artery disease

Plus: You must be enrolled in a Medicare Part D plan or MA-PD plan in 2026, and the medication must be prescribed for weight loss with ongoing lifestyle modification (diet + exercise documentation).

How to Get the $50/Month Price

This part trips people up. The Bridge does not work like a normal Part D prescription. Your Wellcare plan isn't involved in the claim. Instead:

1. Your prescriber writes the prescription for an eligible GLP-1
2. Your prescriber submits the prior authorization to CMS's central processor (Humana) — not to Wellcare
3. The pharmacy collects your $50 copay and bills the central processor
4. The Bridge runs from July 1, 2026 through December 31, 2027 — CMS extended it through 2027 because the BALANCE Model is not launching in Medicare for 2027

Critical caveat: The $50 copay does NOT count toward your Part D True Out-of-Pocket cap. So if you also take other expensive medications, the Bridge medication doesn't help you hit catastrophic coverage faster.

What If You Need a GLP-1 Before July 1, 2026?

Three options:

1. Pursue PA through your PCP for the Wegovy® cardiovascular indication, the Zepbound® OSA indication, or a T2D indication if you have the diagnosis
2. NovoCare cash-pay for Wegovy® (see pricing details below)
3. LillyDirect cash-pay for Zepbound® vials (see pricing details below)

We have a complete walkthrough of the Bridge program here: Read the full Medicare GLP-1 Bridge guide.

Does Centene Medicaid Cover Wegovy or Zepbound? It's a State-by-State Story

States That Cover GLP-1s for Obesity Treatment (Medicaid FFS, January 2026)

According to KFF's January 2026 Medicaid GLP-1 tracker, the 13 states covering GLP-1s for obesity treatment under fee-for-service are:

Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Rhode Island, Tennessee, Utah, Virginia, Wisconsin.

If you have a Centene Medicaid plan in one of these states, weight-loss coverage may be possible — but you still need PA, you still need to meet BMI thresholds, and managed-care rules can apply additional utilization controls.

States That Recently Cut or Restricted Coverage

KFF reports that California, New Hampshire, Pennsylvania, and South Carolina eliminated GLP-1 coverage for obesity treatment after October 2025. North Carolina eliminated coverage and then reinstated it in December 2025. Pennsylvania Medicaid stopped covering GLP-1s for weight loss for adults 21+ effective January 1, 2026 (children and young adults under 21 may still get coverage in some cases).

If you have a Centene Medicaid plan in one of these states, weight-loss-only coverage is generally not available right now — but coverage for FDA-approved non-obesity indications (CV, OSA, T2D, MASH) generally follows Medicaid drug-coverage rules.

What Centene Medicaid Members Should Do

Step 1: Check your state's Medicaid GLP-1 coverage policy. The KFF Medicaid GLP-1 tracker is the cleanest source.

Step 2: Have your in-network PCP submit a PA to the appropriate Centene Medicaid pharmacy benefit. Submission processes vary by state plan — use the form, fax number, or electronic PA channel listed on your plan's pharmacy resources page or your denial notice.

Step 3: If your state doesn't cover for weight loss and you don't have a comorbidity, your real choices become cash-pay paths or waiting until your circumstances change. Don't pay for a telehealth membership thinking it'll get Medicaid to cover the medication — that's not how it works.

Real talk for Medicaid members: This page would happily route you to Ro or Sesame if it would help. It won't. Both platforms publicly state they don't coordinate GLP-1 coverage for government plans. Ro specifically excludes Medicaid members from enrollment. If you click an affiliate link expecting Medicaid billing, you'll just be paying out-of-pocket on top of your Medicaid coverage. Save your money.

Does Ambetter Cover Wegovy or Zepbound? How to Get Approved Through a Coverable Pathway

What You Need to Bring to Your Prescriber Visit

This is the checklist nobody hands you. Bring all of it:

• BMI documentation — current and baseline if you've lost weight on prior medications
• Cardiovascular history — echocardiogram, cath report, prior heart attack records, stroke documentation, or peripheral artery disease imaging if applicable
• Sleep study results — if you're going for the Zepbound® OSA pathway, bring your AHI score and severity classification
• Liver imaging or biopsy — if you're going for the Wegovy® MASH pathway, you need confirmation of stage F2 or F3 fibrosis
• 6 months of physician-directed weight loss program records — diet/exercise logs, behavioral counseling notes, prior medication trials
• Type 2 diabetes documentation — A1c results if applicable
• Step therapy documentation — for Wegovy® CV indication with concurrent T2D, you'll need records of trying Ozempic®/Rybelsus®, Trulicity®, and Victoza® unless contraindicated or intolerable
• Current medication list — any GLP-1 receptor agonist you're already on
• Cardiovascular standard-of-care documentation — current statins, antihypertensives, antiplatelets

How the PA Submission Works

Your prescriber's office submits the Prior Authorization Request Form for Non-Specialty Drugs through your Ambetter plan's pharmacy benefit channel. Ambetter's pharmacy resources list Centene Pharmacy Services fax 1-800-977-4170 and CoverMyMeds (electronic PA) for Ambetter pharmacy prior authorizations. Medicaid and Wellcare members should use the fax/ePA instructions printed on their state plan form, drug-list tool, or denial notice — not the Ambetter line.

Approval Duration and Timing

• Initial approval: 6 months
• First renewal: Requires documented ≥5% baseline body weight loss
• Subsequent renewals: Requires maintained weight loss

Centene says PA review can take one day, a few days, or longer depending on the medication and whether more clinical information is needed. Use your plan's PA notice or denial letter for the exact timeline.

If you didn't lose 5% by month 6, the renewal is denied and you start over. That's why getting a real lifestyle intervention program in place from day one matters — it's not just box-checking, it's the thing that keeps your medication covered next year.

If Centene Denies Your Prescription: Three Real Backup Paths

Path 1: Appeal the Denial

KFF found that 80.7% of appealed Medicare Advantage prior authorization denials were partially or fully overturned in 2024, while only 11.5% of denied MA prior authorization requests were ever appealed. That data isn't GLP-1-specific or Ambetter-specific, but it tells you something important: appeals matter, and most people don't bother. Don't be most people.

Start by reading the denial letter for the specific reason code:

Use the deadline and appeal channel printed on your denial or coverage-determination notice. Marketplace plans commonly use a 180-day internal appeal window, but Medicare Part D, Medicare Advantage, and Medicaid managed-care appeals follow different timelines and may use different external-review or fair-hearing processes. Appeals citing a clear FDA-approved comorbidity indication, paired with a Letter of Medical Necessity from your prescriber, have the strongest success rate.

Path 2: Cash-Pay FDA-Approved Brand-Name Medication

This is the cleanest fallback for a denied Ambetter or Wellcare member who wants FDA-approved medication.

These prices apply with a valid prescription regardless of whether your Centene plan covers the medication. Both Ro and Sesame Care can route prescriptions to NovoCare or LillyDirect for cash-pay.

Path 3: Compounded GLP-1s (With Eyes Open)

A blunt fact most affiliate sites won't tell you: compounded GLP-1 medications are not FDA-approved drug products and don't go through FDA premarket review for safety, effectiveness, and quality. FDA oversight of compounding also differs by setting — state-licensed 503A pharmacies and FDA-registered 503B outsourcing facilities are regulated differently. The FDA has issued warning letters to several telehealth companies about misleading marketing of compounded GLP-1s.

There's also active regulatory movement here: as of late April / early May 2026, the FDA has proposed not to include semaglutide, tirzepatide, or liraglutide on the 503B Bulks List, and the agency has stated that semaglutide and tirzepatide are not currently on FDA's drug shortage list. Re-verify the current FDA position before recommending any compounded route.

That said, some Centene members whose PA was denied and who can't afford brand-name cash-pay compare compounded GLP-1 programs as a lower-cost cash-pay route. That route is separate from Centene coverage and requires extra sourcing and pharmacy verification. If you go this route, ask your provider to disclose whether the medication comes from a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility, and verify that pharmacy or facility directly. Ask for a Certificate of Analysis on the product. Accreditation through PCAB (Pharmacy Compounding Accreditation Board) or NABP and a Certificate of Analysis are useful screening signals — not FDA approval of the medication.

Worth knowing for the right reader: MEDVi is one of the deeper-menu compounded options (verify current pricing and pharmacy disclosures before signing up), Eden is a mainstream-feeling compounded option with HSA/FSA flexibility, and SHED specializes in oral and sublingual compounded formulations for needle-averse patients.

What This Will Actually Cost You: The Real Numbers

Pricing verified May 2, 2026 against ro.co, sesamecare.com, novocare.com, and lillydirect.lilly.com. Pricing changes — verify on the provider's site at the time you start.

What We Actually Verified for This Page

We don't paste claims and hope. Every fact on this page was checked against a primary source on May 2, 2026:

If you spot something out of date, tell us — we update this page regularly.

When NOT to Use a Telehealth GLP-1 Provider (And Use Your Plan Network Instead)

You should use your plan's in-network provider directory — not a paid telehealth subscription — if any of these apply:

• You have Centene Medicaid and need actual Medicaid pharmacy billing
• You have Wellcare Medicare and want true Part D coverage (or you're preparing for the July 2026 Bridge — your in-network PCP can handle the Bridge PA submission)
• You have a complex history involving endocrine, cardiac, kidney, liver, pregnancy, or eating-disorder considerations
• You already have an established relationship with an endocrinologist, cardiologist, bariatric specialist, or obesity-medicine physician
• Your denial letter cites plan-specific criteria that need a peer-to-peer review or external appeal
• You want the doctor visit itself billed to insurance, not paid out-of-pocket

The right reader for Ro or Sesame is an Ambetter Marketplace member (or another commercial-plan holder) who wants the convenience of telehealth, the leverage of a dedicated insurance concierge, and access to the FDA-approved brand-name medications they carry. The wrong reader is a Wellcare or Medicaid member who would just pay a subscription fee on top of insurance that already covers the visit.

We'd rather you not click an affiliate link if it's wrong for you. That's how you can trust the recommendations on this page.

A Note on Public Reviews of Ro's Insurance Process

A note on testimonials: we only reference real, attributable feedback. We're not making up quotes.

A common point of frustration in Ro's public reviews — including on consumer review sites — is members being surprised that the membership fee doesn't include the medication. That's exactly why we put the cost split front and center on this page. Membership: $39 first month, $149/month ongoing (or $74/month with annual prepay). Medication: separate, billed through insurance if covered or at NovoCare/LillyDirect's manufacturer cash price if not.

When members are clear on that split going in, the experience reports change. The free Coverage Checker is the move we recommend for any Ambetter member: get the report first, decide afterward.

Still Not Sure Which Path Is Right for You?

You've read all of this and you're still on the fence. That's normal — Centene has more moving parts than most insurance brands because it operates Marketplace, Medicare, and Medicaid lines simultaneously, and the right move depends on details only you know.

Take our free 60-second GLP-1 path quiz. Tell us your plan name, state, and what you're trying to accomplish. We'll route you to the exact next step — whether that's a free Ro coverage check, the Medicare GLP-1 Bridge guide, your in-network plan portal, or a different path we didn't cover above.

How We Built This Guide

We pulled Centene's published clinical policies for Wegovy® and Zepbound® directly from the Centene/Ambetter PDF library. We verified Wellcare's current Medicare coverage rules from Wellcare's own resource page. We pulled Bridge eligibility, drug list, and processor details from CMS's Medicare GLP-1 Bridge page. We verified Medicaid state coverage from KFF's January 2026 tracker. We verified each telehealth provider's prior-authorization-handling claim against the provider's own published documentation. Every commercial pricing number was checked against the source on May 2, 2026.

The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. Our recommendations are based on plan fit, verified pricing, insurance limitations, and reader safety — in that order. We earn a commission from some affiliate links, but it does not change which providers we recommend or how we present limitations.

If your situation doesn't match any of the paths above, contact us — we read every message.

This guide is for coverage research and provider comparison. It is not medical advice. Always work with a licensed healthcare provider for prescribing and monitoring decisions. Insurance coverage rules, plan formularies, prior authorization criteria, and pricing change frequently — verify with your specific plan and provider before acting.